Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.

Treatment with romosozumab + alendronate vs alendronate alone led to improvements in tissue thickness-adjusted trabecular bone scores among postmenopausal women with osteoporosis. The study included ...

Herein, we have constructed an alendronate (ALN)-conjoined injectable tetra-PEG hydrogel with excellent biocompatibility, uniform network, and favorable mechanical properties in one-pot strategy. In ...